1 |
Inaba H,Greaves M,Mullighan CG. Acute lymphoblastic leukaemia[J]. Lancet, 2013, 381(9881): 1943-1955.
|
2 |
Hunger SP,Lu X,Devidas M, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group[J]. J Clin Oncol, 2012, 30(14): 1663-1669.
|
3 |
Katsuya H,Ishitsuka K,Utsunomiya A, et al. Treatment and survival among 1594 patients with ATL[J]. Blood, 2015, 126(24): 2570-2577.
|
4 |
Othus M,Appelbaum FR,Petersdorf SH, et al. Fate of patients with newly diagnosed acute myeloid leukemia who fail primary induction therapy[J]. Biol Blood Marrow Transplant, 2015, 21(3): 559-564.
|
5 |
Lazarus HM. Acute leukemia in adults: novel allogeneic transplant strategies[J]. Hematology, 2012, 17(Suppl 1): S47-S51.
|
6 |
Ho AD,Schetelig J,Bochtler T, et al. Allogeneic stem cell transplantation improves survival in patients with acute myeloid leukemia characterized by a high allelic ratio of mutant FLT3-ITD[J]. Biol Blood Marrow Transplant, 2016, 22(3): 462-469.
|
7 |
Devillier R,Harbi S,Fürst S, et al. Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation[J]. Biol Blood Marrow Transplant, 2014, 20(10): 1560-1565.
|
8 |
Ruggeri A,Labopin M,Sanz G, et al. Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia[J]. Leukemia, 2015, 29(9): 1891-1900.
|
9 |
Zheng C,Zhu X,Tang B, et al. Comparative analysis of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation in children with high-risk or advanced acute leukemia[J]. Ann Hematol, 2015, 94(3): 473-480.
|
10 |
Paschka P,Du J,Schlenk RF, et al. Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML study group (AMLSG)[J]. Blood, 2013, 121(1): 170-177.
|
11 |
Goldstone AH,Richards SM,Lazarus HM, et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL Ⅻ/ECOG E2993)[J]. Blood, 2008, 111(4): 1827-1833.
|
12 |
Smith M,Arthur D,Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia[J]. J Clin Oncol, 1996, 14(1): 18-24.
|
13 |
Creutzig U,Zimmermann M,Ritter J, et al. Definition of a standard-risk group in children with AML[J]. Br J Haematol, 1999, 104(3): 630-639.
|
14 |
Sander A,Zimmermann M,Dworzak M, et al. Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials[J]. Leukemia, 2010, 24(8): 1422-1428.
|
15 |
Konuma T,Kato S,Oiwa-Monna M, et al. Comparison of graft-versus-host disease-free, relapse-free survival of transplantation using matched sibling donor, matched unrelated donor or unrelated cord blood after myeloablative conditioning for adult patients with hematological malignancies[J]. Leuk Lymphoma, 2016, 57(9): 2126-2132.
|
16 |
Crisinel PA,Duval M,Crisinel D, et al. Risk of cytomegalovirus infection and disease after umbilical cord blood transplantation in children[J]. Can J Infect Dis Med Microbiol, 2013, 24(1): e11- e15.
|
17 |
Morishita S,Kaida K,Yamauchi S, et al. Early-phase differences in health-related quality of life, psychological status, and physical function between human leucocyte antigen-haploidentical and other allogeneic haematopoietic stem cell transplantation recipients[J]. Eur J Oncol Nurs, 2015, 19(5): 443-450.
|
18 |
Wang L,Liu H,Geng L, et al. Efficacy analysis of unrelated cord blood transplantation for 58 acute myelogenous leukemia patientsClinical analysis of 58 cases of acute myeloid leukemia treated with unrelated umbilical cord blood transplantation[J]. Chin J Hematol, 2015, 36(8): 637-641.
|
19 |
Glucksberg H,Storb R,Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors[J]. Transplantation, 1974, 18(4): 295-304.
|
20 |
Cheson BD,Bennett JM,Kopecky KJ, et al. Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia[J]. J Clin Oncol, 2003, 21(24): 4642-4649.
|
21 |
Liu HL,Sun ZM,Geng LQ, et al. Similar survival, but better quality of life after myeloablative transplantation using unrelated cord blood vs matched sibling donors in adults with hematologic malignancies[J]. Bone Marrow Transplant, 2014, 49(8): 1063-1069.
|
22 |
Marks DI,Woo KA,Zhong X, et al. Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors[J]. Haematologica, 2014, 99(2): 322-328.
|
23 |
汪丽钰,刘会兰,耿良权, 等. 非血缘脐血移植治疗急性髓系白血病58例疗效分析[J]. 中华血液学杂志, 2015, 36(8): 637-641.
|
24 |
Scaradavou A,Brunstein CG,Eapen M, et al. Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia[J]. Blood, 2013, 121(5): 752-758.
|
25 |
Verneris MR,Brunstein CG,Barker J, et al. Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units[J]. Blood, 2009, 114(19): 4293-4299.
|
26 |
Sanz J,Sanz MA,Saavedra S, et al. Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia[J]. Biol Blood Marrow Transplant, 2010, 16(1): 86-94.
|
27 |
Arai Y,Takeda J,Aoki K, et al. Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy[J]. Blood, 2015, 126(3): 415-422.
|
28 |
Ponce DM,Hilden P,Devlin SM, et al. High disease-free survival with enhanced protection against relapse after double-unit cord blood transplantation when compared with T cell-depleted unrelated donor transplantation in patients with acute leukemia and chronic myelogenous leukemia[J]. Biol Blood Marrow Transplant, 2015, 21(11): 1985-1993.
|
29 |
Chevallier P,Labopin M,Socie G, et al. Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto-SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM-TC[J]. Eur J Haematol, 2015, 94(5): 449-455.
|
30 |
Parody R,Martino R,de la Cámara R, et al. Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time[J]. Bone Marrow Transplant, 2015, 50(2): 274-281.
|
31 |
Riches ML,Trifilio S,Chen M, et al. Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis[J]. Bone Marrow Transplant, 2016, 51(2): 322.
|
32 |
Marinho DH,Neto JZ,Bonfim CM, et al. Unrelated hematopoietic stem cell transplantation in the pediatric population: single institution experience[J]. Rev Bras Hematol Hemoter, 2015, 37(4): 236-241.
|
33 |
Bachanova V,Burns LJ,Wang T, et al. Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor[J]. Bone Marrow Transplant, 2015, 50(2): 197-203.
|